[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
PRISM MarketView @PrismMarketView on x 4696 followers
Created: 2025-07-18 11:07:59 UTC
Mesoblast (Nasdaq: $MESO) is up XX% premarket after reporting $13.2M in first-quarter sales of Ryoncil, its FDA-approved cell therapy for pediatric SR-aGvHD.
With broad U.S. coverage now in place and more transplant centers coming online, the commercial launch is gaining momentum. .@MesoblastNews
XXX engagements
